Page last updated: 2024-10-30

mefenamic acid and Mast-Cell Sarcoma

mefenamic acid has been researched along with Mast-Cell Sarcoma in 1 studies

Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
mefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.

Mast-Cell Sarcoma: A unifocal malignant tumor that consists of atypical pathological MAST CELLS without systemic involvement. It causes local destructive growth in organs other than in skin or bone marrow.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kalbhen, DA1
Wisgens, D1
Domenjoz, R1

Other Studies

1 other study available for mefenamic acid and Mast-Cell Sarcoma

ArticleYear
[Effect of small doses of anti-inflammatory agents on sulfate-S35 incorporation and cell proliferation of neoplastic mast cells in vitro].
    Archives internationales de pharmacodynamie et de therapie, 1970, Volume: 183, Issue:2

    Topics: Amides; Anti-Inflammatory Agents; Butyrates; Cell Division; Chloroquine; Culture Techniques; Dinitro

1970